The AMR Crisis in Emerging Markets

1.27 million deaths were directly attributable to AMR in 2019. 39 million deaths are projected from AMR between 2025–2050. South Asia has the 2nd highest regional AMR death rate at 21.5 per 100K.

Why AMR Surveillance Matters in India, Bangladesh and Kenya

Antimicrobial resistance is one of the most urgent public health threats facing South Asia and Sub-Saharan Africa. India is the world's largest consumer of antibiotics, with over 13 billion defined daily doses consumed annually. Yet fewer than 5% of Indian clinics have access to structured antibiotic susceptibility testing or real-time resistance surveillance. This means the vast majority of antibiotic prescriptions are made without diagnostic evidence, accelerating resistance at a population level. In Bangladesh, cholera and typhoid outbreaks continue to challenge an already strained health system, while multidrug-resistant organisms including ESBL-producing E. coli and carbapenem-resistant Klebsiella pneumoniae are increasingly detected in community settings. In Kenya, MRSA and drug-resistant tuberculosis represent growing threats, particularly in rural clinics with limited laboratory infrastructure.

OGENProAI addresses this gap through a patented 7-layer One Health AMR surveillance architecture. At the point of care, clinics use rapid immunoassay diagnostic kits with embedded QR codes. Scanning the QR code automatically captures the kit ID, test type, and batch number into the patient encounter record — creating a closed loop from physical diagnostic kit to digital surveillance data. Laboratory AST results, molecular POC outputs from Truenat, GeneXpert and Genes2Me AMR-Q, and EHR prescribing data are all ingested through an encrypted multi-source API pipeline. An AI processing engine generates real-time antibiograms, resistance trend predictions, WHO AWaRe prescribing analytics and zoonotic AMR risk scores — all aligned to EUCAST and CLSI breakpoint standards.

The One Health framework underpins everything OGENProAI does. Resistance genes detected in livestock and poultry farms can transfer to human pathogens through food chains and water systems. OGENProAI integrates veterinary and farm antibiotic usage data alongside human clinical surveillance, enabling cross-species resistance signal detection. Government health authorities access WHO GLASS compatible surveillance reports, district and state level AMR heatmaps, and early warning outbreak intelligence — all from a single platform. OGENProAI is currently onboarding pilot clinics across India for its April/May 2026 launch. View our pricing plans or try the live demo today.

7-Layer One Health Architecture

Patent Pending — Diagnostic Input, Scanning Interfaces, Encrypted API Pipeline, Dual Database, AI Processing Engine, Role-Specific Dashboards, End Users & WHO Reporting.

Solutions for Every Healthcare Role

For Clinics & Doctors — Real-time EHR with AMR alerts and WHO AWaRe prescribing guidance
For Labs & Diagnostics — Structured AST result entry with EUCAST/CLSI auto-classification
For Government & Public Health — National AMR surveillance with WHO GLASS compatible exports
For Veterinary & Farm — Farm antibiogram and zoonotic spillover alerts
For Dental Clinics — Complete dental EHR with FDI tooth charting and AMR-aware prescribing

From Physical Kit to Digital Record

Proprietary closed-loop diagnostic workflow: Scan QR on diagnostic kit, auto-fill patient encounter data, trigger AMR surveillance alert.

Launching Q2 2026 — Pilot Program Open

We are onboarding 10-20 partner clinics in India for our April/May 2026 pilot. Early partners get 6 months free access. Apply for Pilot Program.